AI assistant
AbbVie Inc. — Director's Dealing 2015
Feb 23, 2015
29755_dirs_2015-02-23_0d7be3df-f645-4439-8bf7-7623b19f36af.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2015-02-19
Reporting Person: SEVERINO MICHAEL (EVP, R&D and CSO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-02-19 | Common stock, $0.01 par value | A | 52860 | — | Acquired | 194485 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-02-19 | Option (right to buy) | $58.88 | A | 104480 | Acquired | 2025-02-18 | Common stock (104480) | Direct |
Footnotes
F1: This stock represents performance vested restricted stock under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have a stock withheld for tax purposes.
F2: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 34,827 on 02/19/2016, 34,826 on 02/19/2017, and 34,826 on 02/19/2018.